Launching a pharmaceutical brand is one of the most high-stakes media challenges in any industry. The window is narrow, the audience is specialized, and the regulatory environment adds layers of complexity that most marketers never encounter.

After supporting dozens of brand launches across oncology, endocrinology, immunology, and more, I've seen the same mistakes surface again and again. Here are the five most expensive ones — and how to avoid them.

1. Treating HCP Media Like Consumer Media

This is the most common and most costly mistake. Teams that come from consumer marketing — or agencies that primarily serve consumer brands — tend to apply the same playbook: maximize reach, optimize for impressions, and report on CPMs.

But HCP media doesn't work that way. Your audience might be 15,000 specialists nationwide. Reach is finite. What matters is frequency, relevance, and channel sequencing — not how many impressions you can buy.

The fix: Start with your HCP universe, not your media budget. Map the audience first, then design the media architecture around how they consume information.

2. Over-Investing in a Single Channel

First-time launchers often put the majority of their budget into one "proven" channel — usually endemic journal advertising or a single programmatic health platform. It feels safe, but it creates dangerous concentration risk.

If that channel underperforms, or if your HCPs aren't as active there as the vendor promised, you've burned through launch budget with no fallback.

The fix: Build a diversified channel mix from day one. Allocate across endemic, non-endemic, programmatic, point-of-care, and digital channels — with clear criteria for reallocation based on early performance signals.

3. No Measurement Framework Before Launch

Too many teams launch media first and figure out measurement later. By the time they realize they can't connect media activity to meaningful outcomes, months of budget have been spent with no learning.

The fix: Define your KPIs and measurement approach before the first dollar is spent. What does success look like at 30, 60, and 90 days? What leading indicators will tell you if the plan is working? How will you attribute downstream engagement back to media touchpoints?

4. Letting Vendors Set the Strategy

Media vendors — DSPs, endemic publishers, point-of-care networks — are incentivized to sell their inventory. That doesn't make them bad partners, but it does mean they're not objective advisors on your media mix.

When there's no senior strategist on the brand side evaluating vendor recommendations, plans tend to skew toward whatever the most persuasive vendor is selling. Budgets get allocated based on sales pitches, not strategic fit.

The fix: Have an independent strategic layer — someone who evaluates vendor proposals against your brand's actual needs, negotiates terms, and holds partners accountable to performance benchmarks.

5. Disconnecting Media from Field Strategy

In pharma, paid media and field sales should be two sides of the same engagement strategy. But in practice, they're often planned in silos. The media team buys awareness. The field team runs their own playbook. Neither knows what the other is doing.

The result: HCPs get inconsistent messaging, and the brand misses opportunities to reinforce media exposure through rep interactions (and vice versa).

The fix: Design media plans that integrate with your field strategy. Use media to warm up targets before rep visits. Use rep intelligence to refine media targeting. Build feedback loops between channels.

The Common Thread

All five of these mistakes share a root cause: no senior strategic oversight on the media investment. The planner is executing. The vendors are selling. But no one is asking whether the overall approach is right.

That's the gap Cadence Health Media was built to fill — bringing senior-level media strategy to brands that can't afford to learn these lessons the expensive way.